The Neurology Podcast provides practical information for neurologists and clinicians to practice the best possible medicine for patients. Examining methods and findings in peer-reviewed journals, the show provides insights that impact clinical practice and patient care. From the journal Neurology and the American Academy of Neurology, providing education and expert analysis since 2007.
https://www.neurology.org/podcast
September 17 2013 Issue
1) Helsinki model cutting stroke thrombolysis delays and 2) Topic of the month: Living Legends Interviews. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Andy Southerland interviews Dr. Atte Meretoja about his paper on Helsinki model cutting stroke thrombolysis delays. Dr. Roy Strowd is reading our e-Pearl of the week about transient global amnesia. In the next part of the podcast Dr. Stacey Clardy interviews Dr. Vanda Lennon about establishing the Neuroimmunology Laboratory at the Mayo Clinic, her contribution to the field of neurology and advice to our younger listeners now beginning their careers. The participants had nothing to disclose except Drs. Southerland, Meretoja, Strowd, Clardy and Lennon.Dr. Southerland serves as Podcast Deputy Editor for Neurology® and serves as Clinical Research Advisor for Totier Technologies, Inc. Dr. Meretoja serves as an editorial board member of the International Journal of Stroke; receives research support from Sigrid Juselius Foundation, Biomedicum Helsinki Foundation and Finnish Medical Foundation.Dr. Strowd serves on the editorial team for the Neurology® Resident and Fellow Section. Dr. Clardy served on the editorial team for the Neurology® Resident and Fellow Section.Dr. Lennon performs service testing for aquaporin-4 autoantibodies on behalf of Mayo Collaborative Service Inc., an agency of Mayo Foundation; receives royalties and license fee payments for the intellectual property: Marker for Neuromyelitis Optica; receives research support from the NIH.